期刊文献+

胸腹腔积液离心石蜡包埋在病理诊断中的价值 被引量:2

下载PDF
导出
摘要 目的探讨离心石蜡包埋和免疫组化在临床胸腹腔积液病理鉴别诊断中应用价值。方法胸腹腔积液标本100例,离心石蜡包埋后行HE染色和免疫组化染色观察,并与常规涂片比较诊断结果。结果判定100例标本中鳞状细胞癌1例,恶性上皮型间皮瘤5例,腺癌27例,间皮细胞增生67例。讨论胸腹腔积液离心石蜡包埋有助于提高其病理诊断阳性率,判断肿瘤原发部位,评估预后,指导治疗方案的选择。
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2011年第11期1234-1237,共4页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献3

二级参考文献26

  • 1杨玲,谭立欣,贾支朝,古媛.肺癌患者69例血清肿瘤标记物测定分析[J].中国现代医药杂志,2006,8(2):20-22. 被引量:8
  • 2曹建新,孟宪镛,倪润洲,刘艳华,陈秀玲.腹水糖抗原50及癌胚抗原对良恶性腹水鉴别价值探讨[J].中国实用内科杂志,1997,17(2):100-101. 被引量:7
  • 3Ordonez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serouseareinomas.Am J Surg Pathol, 1998, 22(10): 1203 - 1214.
  • 4Doglioni C, Tos AP, Laurinol, et al. CAL: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol, 1996,20(9) : 1037 - 1046.
  • 5Ordonez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serouscarcinomas.Am J Surg Pathol, 1998, 22(10): 1203 - 1214
  • 6Doglioni C, Tos AP, Laurinol, et al. CAL: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol, 1996,20(9): 1037 - 1046
  • 7Chu A Y, Litzky L A, Pasha T L, et al. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma [ J ] .Mod Pathol,2005,18 : 105 - 110.
  • 8Comin C E, Saieva C, Messerini L. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary [ J ]. Am J Surg Pathol,2007,31 ( 8 ) : 1139 - 1148.
  • 9Sawazaki H, Yoshikawa T, Takahashi T, et al. Renal cell carcinoma with malignant pleural mesothelioma after asbestos exposure: a case report[ J]. Hinyokika Kiyo,2007,53 ( 11 ) :805 - 808.
  • 10Mimura T, Ito A, Sakuma T, et al. Novel marker D2-4-0, combined with calretinin, CEA, and TTF-1 : an optimal set of immunodiagnostic markers for pleural mesothelioma[ J]. Cancer,2007, 109(5) :933 -938.

共引文献21

同被引文献19

  • 1Yukio Takeshima Y, Amatya V J, Kushitani K, et al. A useful antibody panel for differential diagnosis between peritoneal mesothelioma and o- varian serous carcinoma in Japanese cases[ J]. Am J Clin Pathol, 2008, 130:771-779.
  • 2Hecht JL, Lee BH, Pinkus JL, et al. The value of wilms tumor suscepti- bility gene 1 in cytologic preparations as a marker for malignant mesothe- lioma[J]. Cancer, 2002, 96 (2) :105-109.
  • 3Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neo- plasms : an immunohistochemical study of 509 cases [ J ]. Mod Pathol, 2002, 15 (1) :6-10.
  • 4DabbsDJ.诊断免疫组织化学[M].周庚寅,翟启辉,张庆慧译.2版.北京:北京大学出版社,2008:375.
  • 5Takn S, Gtimti Y, Kiremiti S, et al. Malignant peritoneal mesothelioma presented as peritoneal adenocarcinoma or primary ovarian cancer: Case series and review of the clinical and immunohistochemical features [ J ]. Int J Clin Exp Pathol, 2012, 5(5) :472-478.
  • 6Ozcan A, Shen SS, Hamilton C, et al. PAX8 expression in non-neoplas- tic tissues, primary tumors, and metastatic tumors : a comprehensive im- munohistochemical study [ J ]. Mod Patho1,2011,24 ( 6 ) :751-764.
  • 7Brenne K, Nymoen DA, Reich R, et al. PRAME (preferentially ex- pressed antigen of melanoma) is a novel marker for differentiating serous carcinoma from malignant mesothelioma[ J]. Am J Clin Pathol, 2012, 137(2) :240-247.
  • 8Myong NH. Thyroid transcription factor-1 ( TTF-1 ) expression in hu- man lung carcinomas:its prognostic implication and relationship with expression of p53 and Ki-67 proteins[ J]. J Korean Med Sci,2003,18 (4) :494-500.
  • 9Kaufmann O, Dietel M. Thyroid transerip tion factor-1 is the superior immunohistochemieal marker for pulmonary adenocareinomas and large cell carcinomas compared to surfactant proteinsA and B [ J ]. Histopathology,2000,36( 1 ) :8-16.
  • 10杨霞,姚宇琪,王娟.液基细胞学(LPT)在体腔积液检查诊断中的应用[J].中国实验诊断学,2009,13(2):194-196. 被引量:3

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部